Tenaya Therapeutics, Inc.

NASDAQ:TNYA

Biotechnology

Healthcare
$0.31 -0.58%

-$0.00 today

Market cap
$69.95M
Beta
2.82
P/E (TTM)
-1.3
EPS (TTM)
-$0.54
52W Low $0.53High $2.35

Volume 2.77M

Average 3.79M

TNYA Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Tenaya Therapeutics, Inc.NASDAQ: TNYA

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 152.97M shares rose 39.2% year over year, behind the +71.7% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +50.6% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +39.2% toward the trailing-twelve-month pace of +71.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
152.97M+0.0% QoQ
Last fiscal yearDec 2025
152.97M+80.3% YoY
LTMMar 2026
158.02M+71.7% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+39.2%——
1 year+80.3%——
3-year CAGR+50.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
152.97M USD
Year-over-year change
+80.3%
4-year CAGR
+38.7%

Weighted Avg Shares (Diluted) vs competitors

How TNYA compares with its peers on the latest reported figures

  • TNYA's LTM Mar 2026 weighted avg shares (diluted) of 158.02M shares is the 2nd highest of the 11 companies compared; the peer median is 63.58M shares.
  • Its year-over-year change of +71.7% is the highest of 11, against a peer median of +3.2%.
  • Over three fiscal years its annual growth of +50.6% compares with a peer median of +15.4%.
TNYA Competitors Peer median
Weighted Avg Shares (Diluted) for TNYA and competitors
Company Period LTM YoY 3-year CAGR
HUMAHumacyte, Inc.LTM Mar 2026167.44M +37.0%+15.3%
TNYATenaya Therapeutics, Inc.LTM Mar 2026158.02M +71.7%+50.6%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026126.35M +0.5%+0.4%
CRBUCaribou Biosciences, Inc.LTM Mar 202694.18M +3.6%+15.4%
PRLDPrelude Therapeutics IncorporatedLTM Mar 202674.4M -1.9%+17.6%
FHTXFoghorn Therapeutics Inc.LTM Mar 202664.63M +7.9%+14.8%
PYXSPyxis Oncology, Inc.LTM Mar 202662.52M +2.9%+23.4%
ABEOAbeona Therapeutics Inc.LTM Mar 202660.91M +28.1%+103.4%
VYGRVoyager Therapeutics, Inc.LTM Mar 202658.91M +1.6%+15.2%
IMRXImmuneering CorporationLTM Mar 202640.92M +29.8%+18.6%
ENTAEnanta Pharmaceuticals, Inc.LTM Mar 202621.37M +0.6%+1.2%
Peer median (excluding TNYA) 63.58M+3.2%+15.4%

Competitors are the stored peer set for TNYA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue4.03M8.71M8.69M8.47M8.44M
Gross Profit(4.03M)(8.71M)(8.69M)(8.47M)(8.44M)
Gross Margin—————
Research & Development54.39M94.54M98.04M86.74M68.61M
Selling, General & Admin14.39M22.37M24.47M20.74M24.72M
Operating Expenses68.78M116.91M122.51M107.48M84.9M
Depreciation & Amortization4.03M8.71M8.69M8.47M8.44M
EBITDA(68.7M)(114.95M)(115.4M)(102.66M)(82.16M)
EBITDA Margin—————
Operating Income(72.81M)(125.62M)(131.19M)(115.95M)(93.33M)
Operating Margin—————
Interest Income108K1.95M7.06M4.74M2.68M
Interest Expense00000
Other Income / Expenses85K1.96M7.11M4.82M2.73M
Income Before Tax(72.72M)(123.67M)(124.08M)(111.13M)(90.6M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(72.72M)(123.67M)(124.08M)(111.13M)(90.6M)
Net Margin—————
EPS (Basic)(1.69)(2.76)(1.68)(1.31)(0.59)
EPS (Diluted)(1.69)(2.76)(1.68)(1.31)(0.59)
Weighted Avg Shares41.29M44.82M73.79M84.82M152.97M
Weighted Avg Shares (Diluted)41.29M44.82M73.79M84.82M152.97M

Tenaya Therapeutics, Inc.

NASDAQ:TNYA

Intrinsic Alpha fair value

Locked

Current Price

$0.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.